HUMIRA for Moderate to Severe Pediatric Crohn’s Disease

HUMIRA for Moderate to Severe Pediatric Crohn’s Disease

What is HUMIRA?

HUMIRA is a prescription medicine used to treat moderate to severe Crohn’s disease in adults and children 6 years of age and older.

HUMIRA Results for Pediatric Crohn’s Disease

With HUMIRA, remission and symptom relief are possible for children 6 years of age and older with moderate to severe Crohn’s disease.

In a clinical study, HUMIRA demonstrated remission and symptom relief.*

REMISSION

Many patients on HUMIRA achieved remission at 26 weeks

Many patients on HUMIRA were in remission at 1 year

SYMPTOM RELIEF

Approximately half of patients on HUMIRA experienced symptom relief at 26 weeks

Many patients on HUMIRA experienced symptom relief at 1 year

*Individual results may vary.

Common side effects of HUMIRA

Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.

Read about the Important Safety Information for HUMIRA.

Humira Complete

Start with support that’s designed around you

HUMIRA Complete gives you access to potential savings, injection training guides, and other helpful resources. Plus, you’re a phone call away from getting help with insurance coverage support.

HUMIRA Dosing for Pediatric Crohn’s Disease

HUMIRA® pen

Important: You must pay attention to your child’s starting dose—it is different from his or her maintenance dose and is a critical part of taking HUMIRA as prescribed. Dosing varies depending on your child's body weight. Always follow the doctor's instructions about when and how often your child should take HUMIRA.

Starting dose

Administered Day 1 and Day 15

Maintenance dose

Can be administered at home every other week

Your child’s first dose of HUMIRA must be given under the supervision of a health care professional. Make sure you have been shown how to administer HUMIRA before you give the treatment to your child. Remember to keep your HUMIRA refrigerated in its original container until ready for use.

Getting started with HUMIRA dosing

Recommended dosing by weight for pediatric Crohn’s patients 6 years of age and older. Dosing varies depending on your child's body weight. Always follow the doctor's instructions about when and how often your child should take HUMIRA.

For children weighing between 17 kg (37 lbs) to less than 40 kg (88 lbs), the recommended Day 1 dosage is 80 mg, the Day 15 dosage is 40 mg, and beginning on Day 29 the dosage is 20 mg every other week.

For children weighing 40 kg (88 lbs) or more, the recommended Day 1 dosage is 160 mg, the Day 15 dosage is 80 mg, and beginning on Day 29 the dosage is 40 mg every other week.

HUMIRA is given by an injection under the skin.

Your child should continue taking HUMIRA as directed by your child’s doctor. Remember, HUMIRA is a treatment, not a cure. Your child’s doctor can tell you if and when your child should stop taking HUMIRA.

For more information, refer to the Patient Instructions for Use and the Medication Guide located inside the HUMIRA carton, and within the Full Prescribing Information. If your child experiences any adverse reactions or discomfort when taking HUMIRA, discuss them with their doctor right away.

Refer to the Patient Instructions for Use to learn about the HUMIRA Pen and prefilled syringe.
Can be given as a single dose in 1 day or split over 2 consecutive days.

How does HUMIRA work?

The protein TNF-alpha is believed to be part of your body’s natural processes involved in creating inflammation, and in some cases, excess inflammation. When used as prescribed, HUMIRA targets and blocks TNF-alpha, which can help reduce excess inflammation associated with pediatric Crohn’s disease.

Already prescribed HUMIRA?

HUMIRA Complete gives you helpful resources and one-to-one support.